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The Antarctic continent is an environment of extreme conditions. Only few research
stations exist that are occupied throughout the year. The German station Neumayer
III and the French-Italian Concordia station are such research platforms and human
outposts. The seasonal shifts of complete daylight (summer) to complete darkness
(winter) as well as massive changes in outside temperatures (down to −80◦C at
Concordia) during winter result in complete confinement of the crews from the outside
world. In addition, the crew at Concordia is subjected to hypobaric hypoxia of∼650 hPa
as the station is situated at high altitude (3,233 m). We studied three expedition crews
at Neumayer III (sea level) (n = 16) and two at Concordia (high altitude) (n = 15) to
determine the effects of hypobaric hypoxia on hormonal/metabolic stress parameters
[endocannabinoids (ECs), catecholamines, and glucocorticoids] and evaluated the
psychological stress over a period of 11 months including winter confinement. In
the Neumayer III (sea level) crew, EC and n-acylethanolamide (NAE) concentrations
increased significantly already at the beginning of the deployment (p < 0.001) whereas
catecholamines and cortisol remained unaffected. Over the year, ECs and NAEs stayed
elevated and fluctuated before slowly decreasing till the end of the deployment. The
classical stress hormones showed small increases in the last third of deployment.
By contrast, at Concordia (high altitude), norepinephrine concentrations increased
significantly at the beginning (p < 0.001) which was paralleled by low EC levels. Prior
to the second half of deployment, norepinephrine declined constantly to end on a low
plateau level, whereas then the EC concentrations increased significantly in this second
period during the overwintering (p < 0.001). Psychometric data showed no significant
changes in the crews at either station. These findings demonstrate that exposition
of healthy humans to the physically challenging extreme environment of Antarctica
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(i) has a distinct modulating effect on stress responses. Additionally, (ii) acute high
altitude/hypobaric hypoxia at the beginning seem to trigger catecholamine release that
downregulates the EC response. These results (iii) are not associated with psychological
stress.
Keywords: endocannabinoids, catecholamines, glucocorticoids, hypobaric hypoxia, high altitude, Antarctica
INTRODUCTION
Humans have an amazing ability to survive in extreme
environments and to acclimatize to varying environmental
conditions ranging from humid tropical forests to polar
deserts (Burtscher et al., 2018; Ilardo and Nielsen, 2018).
Stress hormones and other stress activated systems play an
important role as mediators of acclimatization responses to
changes in the environment (Dhabhar, 2018). To measure these
hormones and evaluate the function of the corresponding and
interacting physiological systems, helps to better understand
such acclimatization processes and thus offers to explore options
to prevent and counteract possible negative responses with
detrimental effects on human physiological integrity.
It was demonstrated that catecholamine and cortisol responses
to physical exercise differ under conditions of normoxia or
hypoxia with higher concentrations under hypoxia (Mazzeo
et al., 1994; Woods et al., 2017). However, the question whether
normobaric and hypobaric hypoxia elicit the same reactions
remains contradictory (Girard et al., 2012; Millet et al., 2012;
Mounier and Brugniaux, 2012). Furthermore, to date, most
studies investigated the consequences of acute or intermittent
hypoxia (Xie et al., 2001; Calbet, 2003; Lusina et al., 2006; Sander,
2016) but data and knowledge about the effect of prolonged and
chronic exposure to hypoxic conditions are rather scarce (Dhar
et al., 2014).
Moreover, the exposure often compasses not only one
environmental stressor (e.g., hypoxia) but demands the
acclimatization to several interacting and combined stressors
(e.g., hypobaric hypoxia and cold) (Burtscher et al., 2018).
In this context, the acclimatization to one stressor was found
to be able to modify and influence the response to the other,
which is called cross-adaptation (Chauhan et al., 2015). It was
evidenced for cold/heat and hypoxia (Launay et al., 2006; Lunt
et al., 2010; Keramidas et al., 2015; Gibson et al., 2017) which
modified their interaction but broad data in this field of research
is still missing due to difficulties of the measure so that a general
conclusion cannot be drawn to date. The same accounts for the
acclimatization response of each individual that seems to be
affected by distinct differences (Bartone et al., 2018).
Besides the sympathoadrenal and glucocorticoid system,
the endocannabinoid system (ECS) plays an important
role in coping with such stress reactions. Its lipid
mediators the endocannabinoids (ECs) and chemically
related N-acylethanolamides (NAEs) are very related with
acclimatization processes at several physiological lines (e.g.,
psychological, metabolic, peripheral, and central nervous
system) in response to environmental factors such as hypobaric
hypoxia and temperature to reach physiological homeostasis
(Campolongo et al., 2009, 2013; Richard et al., 2009; Chouker
et al., 2010; Dlugos et al., 2012; Feuerecker et al., 2012; Hauer
et al., 2013, 2014; Morena et al., 2014; Neumeister et al., 2015;
Hanlon et al., 2016).
We investigated a cohort of healthy male individuals over
12 months including a 9-month overwintering period at two
Antarctic research stations: Neumayer III near the Antarctic coast
in the Queen Maud land and Concordia in Inner East Antarctica.
In general, the Antarctic environment is characterized by
extreme shifts in daylight from 24 h light during the Antarctic
summer to complete 24 h darkness during the winter period as
well as massive changes in outside temperatures at onset of the
Antarctic winter requiring complete confinement of the crew to
the protective research stations. Thus, expeditioners suffer from
sensory deprivation by a monotone environment with lack of
stimuli, restricted food variation, and a distinct social narrowing
with high potential for conflicts (Das et al., 2018). Furthermore,
a disruptive circadian rhythm may influence the hormonal stress
response (Chen et al., 2016; Vitale et al., 2018).
In detail, living conditions at Concordia are more severe and
thus ensue more rigorous changes than at Neumayer III due
to its inland location. Additionally, in contrast to Neumayer III
which is situated at sea level, Concordia is situated at 3,233 m
above sea level inducing an environment of hypobaric hypoxia to
acclimatize to.
We hypothesized that (i) the extreme environmental
conditions would lead to an increase of stress-related hormones
and that (ii) this increase would be aggravated and sustained in
the crew of Concordia Station as of their exposition to long-term,
chronic hypobaric hypoxia.
The aim of our study was to investigate and precise the
modulations of the stress-related ECS in humans exposed
to harsh and extreme environmental living conditions as
represented in Antarctica. The main focus hereby was set on the
changes induced by chronic hypobaric hypoxia.
To confirm our hypothesis, we therefore determined
hormonal/metabolic stress parameters (ECs, catecholamines,
and glucocorticoids) and evaluated the psychological stress level
in three expedition crews at Neumayer III (sea level) and in two
at Concordia (high altitude), respectively.
MATERIALS AND METHODS
Group of Study
In this prospective field study, in total, 15 healthy male
participants were included for the Concordia (high altitude) crew
investigation (seven individuals during the expedition period
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2016 and eight volunteers in 2017) and 16 healthy male crew
members for the Neumayer III (sea level) investigation (five
individuals in 2013, six in 2014, and five in 2015). The crews at
both stations changed in every expedition period so that every
participant was included only once in the study. Demographic
data of the participants are given in Table 1.
Concordia and Neumayer III Research
Station
This study took place at two different Antarctic research stations:
(i) the French-Italian inner-continental station Concordia,
situated at 3,233 m above sea-level (high altitude; pressure level
∼640 to 650 hPa). It is located at a latitude/longitude of 75◦ 06′
S/123◦ 21′ E on an inland high ice plateau area called Dome
C. The closest coastal region is approx. 1,100 km away (ii) the
German coastal Antarctic station Neumayer III which is situated
in the Atka Bay in the northeast Weddell sea on the Ekström
shelf ice at sea level with the coordinates 70◦ 40′ S/8◦ 16′ W.
Seasons in Antarctica are opposite to the northern hemisphere
with Antarctic summer lasting from beginning of November to
beginning of February and winter from May to August. The
longest day (mid-summer) is in December and the shortest
day in June (mid-winter). During the Antarctic summer the
lack of a light/dark cycle results in 24 h of constant sunlight.
During this period, average outside temperatures are around
−50◦C (Concordia, high altitude) and −3◦C (Neumayer III,
sea level). By contrast, during the winter season no sunlight
is present and outside temperatures range around −60◦C and
can drop to −80◦C at Concordia (high altitude) and −30◦C
at Neumayer III (sea level). In addition to the extreme outside
temperatures, humidity is very low especially in inner Antarctica
(Concordia, high altitude) leading to a very dry environment.
Here, precipitation is very little throughout the year.
In order to maintain a regular circadian rhythm in this
environment, a normal day–night cycle is tried to be respected
by keeping regular hours for common meals, working duties, and
evening activities.
In summary, these extreme conditions lead to a complete
isolation (no access/exit possible) from the outer world
during almost 9 months (mid-February to mid-October).
Telecommunication with the outside world from the stations
is possible via phone which can depend on current weather
conditions. The same applies for internet access that is possible
but not always reliable. All supply goods for the over-wintering
period are stored in different areas inside the two stations,
including different fridges and freezers (+4 to−25◦C).
Study Protocol
Data from two expedition campaigns at Concordia (high altitude)
(2016 and 2017) and from three expedition campaigns at
Neumayer III (sea level) (2013–2015) were analyzed. Data
collection and blood sampling for stress hormone analyses in the
study groups were performed on a monthly basis during the first
week of the month and in the morning around 7:00–8:00 am
starting in January/February after arrival of the crew members
and continued through the whole year until October/November
when the station was prepared for the next seasonal change of
crew. One of the authors (CS and MF) was present at Concordia
(high altitude) during December/January (summer season) of
each campaign when the station was accessible by aircraft to
help with the setup of the study protocol and for training of
the crew to maximize study compliance. To establish procedural
processing at Neumayer III (sea level) external assistance from
the study team (AC) was present during the first Antarctic
summer season. The training of the crew surgeons took place
1–3 months before deployment. During the actual overwintering
period, data collection, blood sampling, and processing of the
samples was performed by one of the crew surgeons (FvdB, CD,
BF, HB, and PG-L) who have received several weeks of training in
carrying out research protocols and in the long-term assessment
and monitoring of the crew members during the winter period.
In addition to data collection and blood sampling in
Antarctica, a baseline data collection (BDC) including
blood sampling was performed in Europe. BDC took place
approximately 2–4 months prior to departure to Antarctica and
was performed close to sea level in Bremerhaven, Cologne, or
Berlin, Germany.
This study was carried out in accordance with the
recommendations of the local Ethics Committee of the
University of Munich with written informed consent from
all subjects. All subjects gave written informed consent in
accordance with the Declaration of Helsinki. The protocol was
approved by the local Ethics Committee of the University of
Munich [Protocols# 332-08, 524-15]. All samples were collected
after an 8 h fasting period in the morning around 7:00–8:00
am. Physical exercise was not allowed for 24 h prior to sample
collection.
Biochemical Measurements
Biochemical measurements were performed from blood samples
taken in EDTA tubes for blood cell count, in lithium-heparinized
tubes (S-Monovette R©, Sarstedt, Nümbrecht, Germany) for EC
and NAEs measurements, from saliva (Salivette R©, Sarstedt,
TABLE 1 | Demographic data of participants of the respective campaign and Antarctic station at BDC.
Crew 2016
Concordia
(high altitude)
Crew 2017
Concordia
(high altitude)
Total
Concordia
(high altitude)
Crew 2013
Neumayer III
(sea level)
Crew 2014
Neumayer III
(sea level)
Crew 2015
Neumayer III
(sea level)
Total
Neumayer III
(sea level)
Number (n) 7 8 15 5 6 5 16
Age (years) 43.4 ± 4.6 35.3 ± 3.2 39.1 ± 2.8 33.8 ± 0.9 36.2 ± 3.7 43.4 ± 5.3 37.7 ± 2.3
Body mass index (kg/m2) 24.7 ± 0.6 24.8 ± 1.3 24.7 ± 0.8 27.37 ± 2.2 26.3 ± 1.0 27.1 ± 1.4 26.9 ± 0.8
Data are mean ± SEM.
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Nümbrecht, Germany) for the determination of free cortisol and
from 12 h pooled urine [from 19:00 to 7:00 (nighttime)] for
catecholamine analyses.
All samples were taken in the early morning and after an
overnight fasting period. Blood samples for blood cell count
were stored at ambient temperature until further processing
the same day. Blood samples drawn for ECs were immediately
placed on ice water to prevent temperature effects (Vogeser et al.,
2006). Blood, urine, and saliva samples were frozen immediately
after processing and stored throughout the expedition year at
a minimum temperature of at least −25◦C. The return of the
frozen samples from Concordia (high altitude) and Neumayer
III (sea level) back to Germany was effected by ship and plane
with a strict temperature monitoring assuring a temperature
of at least −25◦C or colder. Samples were stored at −60◦C
(freezer) till further processing and analyses after arrival at
Munich.
Blood Cell Count
EDTA-anti-coagulated blood samples were used to determine
the blood cell count using the on-site QBC Autoread plus
automated analyzing system (QBC Diagnostics, Port Matilda, PA,
United States). Hemoglobin concentration and hematocrit were
quantified.
Endocannabinoid and NAEs Measurements
After sampling, blood samples were immediately centrifuged, the
plasma transferred into Eppendorf tubes and frozen at −60◦C
without any delay (Hauer et al., 2013). This procedure allows
the storage of EC samples for at least 6 months (Di Marzo et al.,
2009).
Plasma concentrations of the ECs anandamide (AEA), 2-
arachidonoylglycerol (2-AG) as well as the N-acyl-ethanolamides
(NAEs) palmitoylethanolamide (PEA), oleoylethanolamide
(OEA), and stearoylethanolamide (SEA) were determined using
a LC-High Resolution LC-MS/MS instrument combination
(Agilent 1290/Sciex Triple TOF 6600) in positive high-resolution
MRM (multiple reaction monitoring, MS resolution ∼16,000)
mode. Chromatographic separation was achieved on a RP-C18
column (Zorbax C8, 2.1 mm × 50 mm, 3.5 µm; Agilent).
Both components of the binary gradient contained a mixture
of 2 mmol aqueous ammonium acetate and ACN at a mixing
ratio of 95+5 (A) and 5+98 (B). Both buffers were moderately
acidified with 0.1% acetic acid. The separation gradient started at
an amount of 10% B which was linearly increased to 100% B at
10 min and was finally kept constant for another 2 min at a flow
rate of 250 µl/min.
Urine Catecholamines
The catecholamines norepinephrine and epinephrine were
determined from pooled nighttime urine samples reflecting the
required conditions of physical inactivity. Nighttime samples
were used to obtain baseline secretion of catecholamines
in contrast to daytime urine samples which reflect physical
challenges and activity throughout the awake phase.
Samples were stored at −60◦C till final processing in
Europe. After defrosting, quantification of catecholamine
concentrations was performed at the Institute of Clinical
Chemistry, University of Munich, Germany, using HPLC
(Chromsystems, Martinsried, Germany). In order to
determine the absolute mass of excreted catecholamines, urine
catecholamine concentrations were multiplied by respective
urine volume.
Saliva Cortisol
Until final measurement, samples were stored frozen at
−60◦C. Cortisol concentrations were quantified by an
electrochemiluminescence immunoassay (Elecsys 2010, Roche,
Mannheim, Germany) at the Institute of Clinical Chemistry,
University of Munich, Germany.
Psychological Evaluation and
Measurements
Two different paper questionnaires were performed to quantify
and analyze each participant’s emotional stress level:
CST (Short Questionnaire on Current Stress)
The test is validated to reflect the level of acute emotional
stress (Current Stress Test, CST) (Müller and Basler, 1993).
It consists of six questions and is highly sensitive to acute
situational changes in subjective stress experience. Six items of
paired positive and negative adjectives referring to perceptions
of current stress and strain or relaxation (e.g., “tense–calm,”
“uneasy–relaxed”) must be rated on a six-point Likert scale.
The range for total item means is 1–6, with higher values
indicating an increased stress experience. The composition of
the questionnaire entails that the subject usually does not
remember the previous ratings, thus preventing carry-over
effects.
Spielberger State Trait Anxiety Inventory (STAI)
It consists of two parts (each 20 questions) rating the answers on a
4-point scale. The score for the global test may range between 40
and 160 points. It evaluates state anxiety (in a specific situation)
or trait anxiety (as part of a person’s character) (Spielberger et al.,
1970).
Statistical Analyses
Normal distribution of sample data was tested using the
Shapiro–Wilk test. Within group comparisons (e.g., changes in
EC levels over time) were performed by one way repeated
measures analysis of variances (one-way RM-ANOVA)
followed by a post hoc Holm–Sidak test to determine which
measurements were significantly different and to correct for
multiple comparisons. Between-group comparisons were
performed using a t-test for normally distributed data and the
Mann–Whitney U test for non-parametric data followed by a
Bonferroni correction for multiple comparisons, respectively.
For all testing, a p-value <0.05 was regarded as statistically
significant. Data are displayed as mean ± SEM. Statistical
calculations were performed using SigmaPlot R© (Systat, Software,
Chicago, IL, United States) and IBM SPSS Statistics v24,
United States.
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RESULTS
Biochemical Measurements
Blood Cell Count (Table 2)
Neumayer III (sea level)
Hemoglobin concentrations were moderately elevated during the
isolation period in February, March, and June to October when
compared to BDC (15.4± 0.18 g/dl, p < 0.05) but still fluctuated
in the normal range. The hematocrit always stayed on a normal
level.
Concordia (high altitude)
Hemoglobin concentrations and hematocrit were significantly
elevated in every month throughout the deployment compared
to BDC with highest values at the end of the stay (Hb BDC
14.4 ± 0.35 g/dl to November 18.5 ± 0.28 g/dl; p < 0.001
versus Hct BDC 0.42 ± 0.01 to November 0.54 ± 0.01;
p < 0.001).
Neumayer (sea level) versus Concordia (high altitude)
Hemoglobin concentrations were significantly higher in the
Concordia (high altitude) crew from February to June, in August,
October, and November (p < 0.05). Hematocrit values were
significantly elevated in the crew at Concordia (high altitude)
compared to the crew at Neumayer III (sea level) in May and at
the end of the stay in October and November (p < 0.001).
Endocannabinoid (EC) and NAEs Plasma
Concentrations (Figures 1A–E)
At BDC in Europe before deployment of the crews to Antarctica,
EC and NAEs values were within the normal range in both crews.
Neumayer III (sea level)
The NAEs and ECs (AEA and 2-AG) increased their
concentrations significantly up to 10-fold from BDC already
at the beginning of the deployment, fluctuated throughout the
year but always on a highly elevated level compared to BDC,
and finally decreased slowly till the end of the deployment
but not returning to BDC values [AEA increased from BDC
0.34 ± 0.02 to 2.53 ± 0.54 ng/ml; p < 0.001 (July). 2-AG from
BDC 22.7 ± 4.23 to 95.74 ± 20.71 ng/ml; p < 0.001 (May). PEA
from BDC 3.15 ± 0.25 to 9.72 ± 1.31 ng/ml; p < 0.001 (April).
OEA from BDC 1.52± 0.26 to 6.73± 1.67 ng/ml, no significance
(July). SEA from BDC 0.97± 0.2 to 5.46± 0.68 ng/ml; p < 0.001
(April)].
Concordia (high altitude)
The NAEs and ECs (AEA and 2-AG) fluctuated on a
constantly low level with intermittent small significant
increases. Significant increases were found at the end of
the deployment [AEA increased from BDC 0.23 ± 0.01
to 0.72 ± 0.04 ng/ml; p < 0.001 (November). 2-AG from
BDC 12.43 ± 2.65 to 23.04 ± 3.09 ng/ml; p < 0.001
(October). PEA from BDC 1.73 ± 0.18 to 4.03 ± 0.29 ng/ml;
p < 0.001 (November). OEA from BDC 0.8 ± 0.12 to
2.46 ± 0.28 ng/ml; p < 0.001 (November). SEA from
BDC 0.97 ± 0.17 to 1.72 ± 0.14 ng/ml; no significance
(November)].
Neumayer III (sea level) versus Concordia (high altitude)
The differences in NAEs and EC (AEA and 2-AG) values between
the crews at Neumayer III (sea level) and Concordia (high
altitude) were highly significant for all neurotransmitters and
nearly throughout the whole isolation period and duration of
stay in Antarctica (AEA June p < 0.05, for all other months
except the end of the stay p < 0.001. 2-AG for all months
p < 0.001 except BDC. PEA October p < 0.05, for all other
months except March, May, and the end of the stay p < 0.001.
OEA May and June p < 0.05, for all other months except BDC,
March, and November p < 0.001. SEA June p < 0.05, for all
other months except BDC, February, March, and November
p < 0.001). At the end of the stay, EC and NAEs scores of the
crews at both stations converged since their concentrations at
Neumayer III (sea level) decreased but increased at Concordia
(high altitude).
TABLE 2 | Hemoglobin concentrations (g/dl) and hematocrit (%).
Neumayer III (sea level) Concordia (high altitude) Neumayer III (sea level) Concordia (high altitude)
Hb (g/dl) Hb (g/dl) Hct (%) Hct (%)
BDC 15.4 ± 0.18 14.4 ± 0.35 47 ± 0.6 42 ± 1#
February 16.4 ± 0.33∗ 17.9 ± 0.28∗,# 49 ± 0.6 52 ± 1.2∗
March 16.6 ± 0.24∗ 18.0 ± 0.24∗,# 49 ± 0.6 51 ± 2.1∗
April 16.1 ± 0.39 17.9 ± 0.20∗,# 48 ± 1.1 53 ± 2∗
May 16.2 ± 0.23 17.8 ± 0.20∗,# 49 ± 0.6 53 ± 0.6∗,#
June 16.3 ± 0.19∗ 17.5 ± 0.17∗,# 49 ± 0.5 51 ± 0.8∗
July 16.5 ± 0.18∗ 17.7 ± 0.33∗ 49 ± 0.5 53 ± 1.1∗
August 16.6 ± 0.23∗ 18.0 ± 0.27∗,# 50 ± 0.7 53 ± 0.8∗
September 16.6 ± 0.36∗ 17.7 ± 0.22∗ 50 ± 0.8 52 ± 0.9∗
October 16.3 ± 0.26∗ 18.4 ± 0.19∗,# 49 ± 0.7 53 ± 0.6∗,#
November 16.1 ± 0.30 18.5 ± 0.28∗,# 48 ± 0.6 54 ± 1∗,#
Data are mean ± SEM. Hb, hemoglobin; Hct, hematocrit; BDC, baseline data collection. ∗Significant difference to BDC. #Significant difference between Neumayer III (sea
level) and Concordia (high altitude).
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FIGURE 1 | Endocannabinoid (EC) and N-acylethanolamide plasma concentrations at Neumayer III (sea level) (n = 7–15) and Concordia (high altitude) (n = 15–16);
data are means ± SEM; units are ng/ml; BDC, baseline data collection; AEA, anandamide (A); 2-AG, 2-arachidonoylglycerol (B); PEA, palmitoylethanolamide (C);
OEA, oleoylethanolamide (D); SEA, stearoylethanolamide (E); ∗significant difference to BDC; #significant difference between Neumayer III (sea level) and Concordia
(high altitude) crews.
Urinary Catecholamine Excretion
Norepinephrine (Figure 2A)
Neumayer III (sea level)
Norepinephrine levels during the night stayed on a consistent
level throughout the confinement and showed no significant
changes. Only toward the end of the months of August and
September, the levels raised albeit not significantly.
Concordia (high altitude)
Nighttime norepinephrine amount increased significantly from
BDC to February (BDC 19.07 ± 1.88 µg to February
42.18 ± 7.87 µg; p < 0.001) and stayed on a significantly
elevated high level until April. Peak values were already reached
in February before levels decreased slowly and constantly till July.
In July, norepinephrine mass plateaued until the end of the stay
at levels similar to BDC.
Neumayer III (sea level) versus Concordia (high altitude)
A significant difference between the nighttime norepinephrine
masses in the crews of the two stations was found in February,
March, and May (p ≤ 0.001 to p < 0.05). The mass of excreted
norepinephrine was constantly higher in the Concordia (high
altitude) crew except for the months August and September.
Calculated SEMs were higher in the Concordia (high altitude)
than in the Neumayer III (sea level) crew and exceeded at the
beginning of the expedition when significant differences between
both stations were stated.
Epinephrine (Figure 2B)
Neumayer III (sea level)
In the Neumayer III (sea level) crew, epinephrine levels during
the night varied inconsistently during the stay and ended at
almost the same level as at BDC.
Concordia (high altitude)
Epinephrine excretion increased in February (from BDC
2.30 ± 0.35 to 4.11 ± 1.17 µg), although without statistical
significance and decreased slowly over the year with little
fluctuations to finally reach BDC levels at the end of the
year.
Neumayer III (sea level) versus Concordia (high altitude)
Epinephrine masses started in both crews at the same level.
During the year, levels were always higher at Concordia (high
altitude) except at the end in the month September but showed
no significant differences between the two crews.
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FIGURE 2 | Norepinephrine (A) and epinephrine (B) in 12-h nighttime urine at Neumayer III (sea level) (n = 11–16) and Concordia (high altitude) (n = 11–15); data are
means ± SEM; units are µg (collection time 12 h); BDC, baseline data collection; ∗significant difference to BDC; #significant difference between Neumayer III (sea
level) and Concordia (high altitude) crews.
Cortisol in Saliva
Morning Cortisol (Figure 3)
Neumayer III (sea level)
Morning cortisol concentrations increased slightly in the first
3 months but without statistical significance and then fluctuated
around the baseline level.
FIGURE 3 | Cortisol in saliva in the morning at Neumayer III (sea level)
(n = 13–16) and Concordia (high altitude) (n = 12–15); data are means ± SEM;
units are µg/dl; BDC, baseline data collection.
Concordia (high altitude)
Morning cortisol concentrations increased until April albeit not
significantly then dropped in May before reaching the maximum
level in June (from BDC 0.37 ± 0.03 to 0.64 ± 0.09 µg/dl).
Afterward, cortisol declined constantly but stayed at a level higher
than at BDC.
Neumayer III (sea level) versus Concordia (high altitude)
During the deployment, cortisol concentrations were nearly
constantly higher in the Concordia (high altitude) crew but
without any significant differences between the two crews.
Evening Cortisol (Data Not Shown)
Evening cortisol concentrations were constantly lower than in
the morning and did not exceed normal values at either station
(Neumayer III (sea level) between 0.12 and 0.22 µg/dl; Concordia
(high altitude) between 0.13 and 0.17 µg/dl). At Concordia (high
altitude), values ranged minimally higher than at Neumayer III
(sea level) during the deployment except at the end of the stay
(August-November). The circadian rhythm was maintained.
Psychological Evaluation and
Measurements
CST (Short Questionnaire on Current Stress) (Table 3)
Neumayer III (sea level)
The acute stress test (CST) revealed no significant changes
throughout the deployment period. Mean CST values in the
morning ranged between 2.2± 0.3 and 2.7± 0.4 points. Evening
results displayed the same pattern (data not shown).
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TABLE 3 | Psychometric data of CST.
CST m Neumayer
III (sea level)
CST m Concordia
(high altitude)
BDC 2.4 ± 0.2 1.9 ± 0.2
February 2.7 ± 0.2 2.0 ± 0.1
March 2.3 ± 0.1 1.9 ± 0.1
April 2.7 ± 0.3 2.0 ± 0.2
May 2.2 ± 0.3 1.9 ± 0.1
June 2.4 ± 0.3 2.0 ± 0.2
July 2.4 ± 0.2 1.7 ± 0.1
August 2.3 ± 0.3 1.9 ± 0.2
September 2.3 ± 0.2 1.9 ± 0.1
October 2.4 ± 0.3 1.9 ± 0.1
November 2.7 ± 0.4 1.8 ± 0.2
Data are mean ± SEM. CST, Current Stress Test; BDC, baseline data collection.
Concordia (high altitude)
No significant changes throughout the deployment period were
detectable, with mean CST values ranging in the morning
between 1.7 ± 0.1 and 2.0 ± 0.1 points. The same results were
measured in the evening (data not shown).
Neumayer III (sea level) versus Concordia (high altitude)
CST scores were consistently higher at Neumayer III (sea level)
than at Concordia (high altitude) independent of the time
point and the time during the day but without any significant
differences between the two crews (evening data not shown).
Spielberger State Trait Anxiety Inventor (STAI)
(Table 4)
Neumayer III (sea level)
Mean state evaluation scores ranged from 32.4± 2.5 to 38.5± 3.4
points whereas the trait assessment showed mean values between
32.3 ± 2.5 and 35.5 ± 3.4 points. No significant changes were
stated.
Concordia (high altitude)
State mean scores at Concordia (high altitude) ranged from
27.3 ± 1.3 to 30.4 ± 2.8 points; trait means ranged between
28.4 ± 1.0 and 29.9 ± 1.5 points. These findings were not
statistically significant.
Neumayer III (sea level) versus Concordia (high altitude)
Between the two crews, the anxiety level (state and trait) was
consistently higher at Neumayer III (sea level) but without any
significant differences.
DISCUSSION
The present study investigated humans during long-term
acclimatization to the highly aversive environment of two
Antarctic research stations. Main focus of the research was to
investigate the effects of hypobaric hypoxia on stress-related
metabolites. Interestingly and contrary to expectations, a massive
increase of these metabolites was observed under normoxic
conditions (Neumayer III, sea level) while concentrations under
hypobaric hypoxia (Concordia, high altitude) stayed low during
the isolation period but enhanced significantly at the end.
Conversely, catecholamines showed an increase at the beginning
of exposure to high altitude being prolonged for norepinephrine
whereas cortisol showed no changes.
It seems that the exposure of humans from a physiologically
familiar to an unknown and physically very challenging
environment triggers this enhanced EC response and that
hypobaric hypoxia modulates this response in terms of a
downregulation. Downregulated expression or lack of increased
expression of ECs in the Concordia (high altitude) crews may
originate in hypoxia signaling and EC metabolism. In the
tumor microenvironment, hypoxia is known to upregulate the
expression of cyclooxygenase-2 (COX-2) via hypoxia-inducible
factor-1 (HIF-1) signaling (Greenhough et al., 2009). COX-2
is one of the enzymes responsible for metabolism of ECs
(Sugimoto et al., 2017) with the main substrates being
AEA and 2-AG (Chiurchiu et al., 2015). Therefore, missing
upregulation of ECs at Concordia (high altitude) might
be due to hypoxia-induced upregulation of COX-2 (and
possibly other enzymes) which in turn oxidizes ECs into
compounds (e.g., prostaglandin-ethanolamides, hydroxy-AEAs)
(Chiurchiu et al., 2015) that were beyond the scope of our
investigations. Furthermore, other dysregulations of degrading
and metabolizing systems of the ECs [e.g., fatty acid amide
hydrolase (FAAH), intracellular transporters] that were not
focus of our study might also have contributed to the stated
downregulation of the ECS.
However, HIF-1α expression under long-term hypobaric
hypoxia seems to be time-dependent. A short-lived transient
activation of HIF-1α-dependent pathways was observed at the
beginning of exposition to high altitude (Bigham and Lee,
2014; Bigham, 2016) but seems to elapse gradually over time
(Petousi et al., 2014). Thus, this regulation pathway seems to
be less significant in acclimatization processes upon long-term
exposition to hypobaric hypoxia (Baze et al., 2010). This is in
good accordance with findings of Feuerecker et al. (2018) who
observed in a former study at Concordia a downregulation of
HIF-1α expression under chronic hypobaric hypoxia. Goyal and
Longo (2014) observed similar results albeit in an animal model.
Against the background of the assumed COX-2 influence on
EC metabolism, one might speculate that this mechanism might
have also contributed to the rising EC levels at Concordia (high
altitude) at the end.
The hypothesis that an unknown and physically challenging
environment triggers enhanced EC responses is in good
accordance with recent studies which demonstrated that the
consequences of strenuous physical conditions (e.g., sleep
restrictions, physical exercise) are able to induce a heightened EC
response (Cedernaes et al., 2016; Hanlon et al., 2016).
In the light of such stressful conditions, we also expected
enhanced catecholamines and cortisol levels due to an elevated
sympathetic tone but surprisingly the stress hormone answers
stayed normal in the Neumayer III (sea level) expeditioners.
One possible explanation for these unexpected observations
derives from the interaction between the EC and the sympathetic
nervous system and the glucocorticoids. During an acute stress
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TABLE 4 | Psychometric data of STAI.
STAI state Neumayer
III (sea level)
STAI state Concordia
(high altitude)
STAI trait Neumayer
III (sea level)
STAI trait Concordia
(high altitude)
BDC 32.4 ± 2.5 28.8 ± 2.0 33.8 ± 2.0 28.4 ± 1.0
February 36.4 ± 2.4 28.6 ± 1.4 32.6 ± 2.3 29.9 ± 1.5
July 34.9 ± 2.3 27.3 ± 1.3 32.3 ± 2.5 29.4 ± 2.0
November 38.5 ± 3.4 30.4 ± 2.8 35.5 ± 3.4 29.6 ± 1.3
Data are mean ± SEM. STAI, Spielberger State Trait Anxiety Inventory; BDC, baseline data collection.
model realized by parabolic flights, subjects who experienced no
motion sickness showed similar results to ours presenting high
EC concentrations and simultaneously low cortisol levels. By
contrast, in subjects with motion sickness, the hormones’ balance
was inversed (Chouker et al., 2010). Increasing EC levels were also
described in a chronic stress model when examining astronauts
on the International Space Station (Strewe et al., 2012).
On the other hand, Yi et al. (2016) reported during a 520 days
lasting confinement in the course of a simulated mission to Mars
a reduction in circulating 2-AG but a significant increase in
urinary norepinephrine and saliva cortisol. The chronic stressor
of confinement resulted here in an interaction of these systems
that is in contrast to our findings albeit it also displays its apparent
inverse character. Moreover, the hypothesis of an inverse
interaction is also supported by Ishac et al. (1996) who stated
an inhibitory effect of presynaptic cannabinoid CB1 receptors
on noradrenaline release in peripheral sympathetic nerves
and Surkin et al. (2018) who evidenced that pharmacological
augmentation of EC signaling reduces the neuroendocrine
response to stress. Niederhoffer and others also found this
inhibitory effect of ECs on noradrenaline to be the cause of
cardiovascular depression (Wagner et al., 1998; Niederhoffer
et al., 2003; Pfitzer et al., 2005). However, opposite reactions
were also described dependent on the acting EC (Kurihara
et al., 2001). Furthermore, the way of interaction seems to vary
dependent on the physiological system that is examined. Indeed,
Simkins et al. (2016) described a positive correlation when
they detected a reduced noradrenergic signaling in the spleen
capsule in the absence of cannabinoid receptors. Additionally,
cannabinoid receptor agonists were shown to induce peripheral
antinociception by activating the noradrenergic system (Romero
et al., 2013) and they increased norepinephrine efflux in the
frontal cortex in an animal model (Page et al., 2008).
By contrast, when analyzing the data of the Concordia (high
altitude) crew, we stated that low EC levels were associated
with significantly increased norepinephrine concentrations and
increased cortisol levels albeit not significant. A former study of
our research group in the same Antarctic environment already
evidenced similar results with elevated catecholamine levels
and assumed their association with stated immune alterations
(Feuerecker et al., 2014). Furthermore, several other studies
in (simulated) high altitude investigated well the impact of
hypobaric hypoxia on sympathoadrenal and adrenocortical stress
responses and found a positive correlation (Calbet, 2003; Simeoni
et al., 2011; Dhar et al., 2014; Aliyev et al., 2017; Woods
et al., 2017). Woods et al. (2017) showed that simulated altitude
under normobaric or hypobaric hypoxia (equivalent to 3,375 m)
appears to induce similar effects in humans than genuine
high altitude. Nevertheless, these effects of hypoxia are also
variable when combined with other co-(stress) factors such as,
e.g., immobilization in bed rest. Thus, we demonstrated in
a former study exposing subjects to 21 days of normobaric
hypoxia (simulated altitude ∼ 4,000 m; 14% O2) and/or bed
rest a reduced sympathoadrenal answer after exposition to
this combination of stressors. Normobaric hypoxia alone did
not induce any significant changes in the catecholamine or
cortisol answer (Strewe et al., 2017). However, the results of
this study suggest a different mechanism of regulation due
to the hypobaric hypoxic environment at Concordia. This
mechanism seems to be based on an inverse interaction of
the sympathoadrenal with the EC response. Hypobaric hypoxia
would therefore either downregulate the EC response or
upregulate the sympathoadrenal answer with subsequently raised
norepinephrine levels which, in turn, would downregulate and
suppress the other system, respectively. The opposite action could
be stated in the Neumayer III (sea level) crew.
The hypothesis of an upregulated sympathoadrenal answer
is supported by the findings while the mission approaches
its end. In the course of time, the sympathoadrenal response
declined gradually and stagnated on a low level at the end.
Here, interestingly, the EC response started to increase and
concentrations of, e.g., AEA and 2-AG were significantly higher
than at BDC.
The increase of ECs and NAEs at Concordia (high altitude)
at the end with the adjustment of the physiological answers
is in line with the hypothesis of a recent study reported by
Alarcon-Yaquetto et al. (2017) who demonstrated significant
higher NAE concentrations in natives of high altitude (3,830 m)
with higher hemoglobin concentration and lower pulse oxygen
saturation. Apparently, the time course and the long-term impact
of the physical conditions seem to play an important role in the
development of the physiological answer. In addition, Feuerecker
et al. (2012) evidenced no changes in the human ECS under
short-term hypobaric hypoxia (altitude of 3,196 m) but only in
its combination with physical effort. The opposite effect of an
enhanced EC response was probably due to the study design
that displayed an acute stress model. Furthermore, Strewe et al.
(2017) found no changes in the ECS when exposing humans
for 21 days to normobaric hypoxia (14% O2 and a simulated
altitude of∼4000 m) either in combination with bed rest or in an
ambulatory setting. Here, the different results may be explained
by the different physical stressors and the shorter time frame.
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Furthermore, differences in reaction and regulation patterns of
the ECS may also vary dependent of the status and type of cell that
is examined (tumor versus healthy cells as mentioned above).
Additionally, in the Concordia (high altitude) crew, great
SEMs for norepinephrine (especially in the first months of
exposition to hypobaric hypoxia), epinephrine, and cortisol
displayed a great inter-individual variability in the concentrations
measured that was not found in the Neumayer III (sea level) crew.
This might express the individual responses of acclimatization to
high altitude in the subjects (Siques et al., 2009; Hermand et al.,
2015; Richalet and Lhuissier, 2015).
In summary, our findings at both Antarctic stations
evidence that human exposure to a physically challenging and
physiologically new and unknown environment with extreme
conditions generates a neuroendocrine reaction pattern of
interacting physiological systems. Herein, high altitude exposure
evokes a significant increase of norepinephrine at the beginning
in contrast to other neuroendocrine parameters. Furthermore,
there seems to be a great variability in the inter-individual
acclimatization responses to high altitude.
As seen by the results in contrast to the baseline data,
the reaction pattern seems to display and express a long-term
acclimatization process of the human body and physiology to
these conditions rather than a pathological process as its intensity
and efficiency diminishes over time to finally return to a nearly
“normal” status.
Furthermore, our results attribute and relate these reactions
to the physical challenge in this environment and do not
support an explanation based on increased psychological
stress. As all inquired stress questionnaires on both stations
negated its presence. However, as a limiting factor, it must be
considered that all participants in such expeditions are highly
motivated and well prepared which might be a reason for the
absence of a distinct psychological effect. Furthermore, such
psychological evaluation tests depend on the motivation and
honesty (manifested self-reflection) of the subject. If one wants
to mask his real feelings and psychological state of mind,
any emotional impairment might just be negated. Moreover, a
constant higher score level in these tests in the Neumayer III (sea
level) crew, albeit in the normal range, might also just display
national differences in carrying out the tests or depend on the
way how the tests were explained to the subjects in the first place.
Limitations
The Neumayer III crew served as control group at sea level to
identify the delta effects of hypobaric hypoxia compared to the
crew at Concordia. This is not an ideal control group as (i) groups
differ in their demographics (BMI) and (ii) not only hypoxia
varies but also all other environmental conditions are alleviated
at the Antarctic coast (e.g., temperatures, wild life, etc.) compared
to Concordia located in inner Antarctica. A better control would
have been either a cross-over study design where the same
subjects would have been exposed to both, low and high altitude
with the same light exposure time, same food, seasonal variations,
and duration of expedition or a longitudinal study design with
the same subjects. However, even in these two design models,
either the same study year (cross-over design) or the different
environmental conditions (low versus high altitude) would not
be applied to the respective investigated subjects. Moreover, both
designs seem however not feasible in this environment from
many perspectives (participants, logistics, costs, and others).
Additionally, daily physical activity and challenge of the
participants as well as their physical conditions and fitness might
interfere with the measures taken so that in an ideal setting
their monitoring would be warranted. Moreover, an investigation
of each individuals’ peculiar physiological response could be
of interest and importance to define personal differences and
potentially identify corresponding groups with similar reaction
patterns.
Furthermore, even though Antarctic climate only changes
slowly due to global climate change and environmental
conditions at both stations stay relatively stable from 1 year to the
other, natural undulations in temperature, humidity, day–night
cycle, etc. exist, and thus, a possible influence on the measures
made cannot fully be excluded.
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